Mirae Asset Global Etfs Holdings Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 62,958 shares of LXRX stock, worth $48,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,958
Previous 47,183
33.43%
Holding current value
$48,477
Previous $79,000
24.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
141Shares Held
238MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$105 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$30 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.49 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.09MShares$6.23 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $145M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...